Suppr超能文献

血栓性微血管病鉴别诊断的诊断性检测

Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies.

作者信息

Zini Gina, De Cristofaro Raimondo

机构信息

Fondazione Policlinico Universitario A. Gemelli IRCCS - Rome, Italy

Institute of Hematology, Università Cattolica del S. Cuore, Rome, Italy

出版信息

Turk J Haematol. 2019 Nov 18;36(4):222-229. doi: 10.4274/tjh.galenos.2019.2019.0165. Epub 2019 Jul 24.

Abstract

Thrombotic microangiopathies (TMAs) are multiple disease entities with different etiopathogeneses, characterized by thrombocytopenia, microangiopathic hemolytic anemia (MAHA) with schistocytosis, variable symptoms including fever, and multi-organ failure such as mild renal impairment and neurological deficits. The two paradigms of TMAs are represented on one hand by acquired thrombotic thrombocytopenic purpura (TTP) and on the other by hemolytic uremic syndrome (HUS). The differential diagnosis between these two paradigmatic forms of TMA is based on the presence of either frank renal failure in HUS or a severe deficiency (<10%) of the zinc-protease ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) in TTP. ADAMTS13 is an enzyme involved in the proteolytic processing of von Willebrand factor (vWF), and its deficiency results in formation of high-molecular-weight vWF-rich microthrombi in the environment of the microvasculature. The presence of these ultra-large vWF multimers in the microcirculation can recruit platelets, promoting multi-organ ischemic lesions. The presence of ADAMTS13 activity at >10% could rule out the presence of a TTP form. However, it is often difficult to differentiate either a TTP or HUS clinical scenario presenting with typical symptoms of TMA. There are in fact several additional diagnoses that should be considered in patients with ADAMTS13 activity of >10%. Widespread inflammation with endothelial damage and adverse reactions to drugs play a central role in the pathogenesis of several forms of TMA, and in these cases, the differential diagnosis should be directed at the underlying disease. Hence, a correct etiologic diagnosis of TMA should involve a critical illness, cancer-associated TMA, drug-induced TMA, and hematopoietic transplant-associated TMA. A complete assessment of all the possible etiologies for TMA symptoms, including acquired or congenital TTP, will allow for a more accurate diagnosis and application of a more appropriate treatment.

摘要

血栓性微血管病(TMA)是多种病因各异的疾病实体,其特征为血小板减少、伴有裂体细胞的微血管病性溶血性贫血(MAHA)、包括发热在内的多种症状,以及多器官功能衰竭,如轻度肾功能损害和神经功能缺损。TMA的两种典型类型,一方面由获得性血栓性血小板减少性紫癜(TTP)代表,另一方面由溶血尿毒综合征(HUS)代表。这两种典型TMA形式的鉴别诊断基于HUS中是否存在明显的肾衰竭,或TTP中锌蛋白酶ADAMTS13(具有血小板反应蛋白1型基序的解聚素和金属蛋白酶,成员13)是否严重缺乏(<10%)。ADAMTS13是一种参与血管性血友病因子(vWF)蛋白水解加工的酶,其缺乏会导致在微血管环境中形成富含高分子量vWF的微血栓。微循环中这些超大vWF多聚体的存在可募集血小板,促进多器官缺血性病变。ADAMTS13活性>10%可排除TTP形式的存在。然而,通常很难区分表现出TMA典型症状的TTP或HUS临床情况。事实上,对于ADAMTS13活性>10%的患者,应考虑几种其他诊断。广泛的炎症伴内皮损伤和药物不良反应在几种形式的TMA发病机制中起核心作用,在这些情况下,鉴别诊断应针对潜在疾病。因此,TMA的正确病因诊断应包括危重病、癌症相关TMA、药物诱导TMA和造血移植相关TMA。对TMA症状的所有可能病因进行全面评估,包括获得性或先天性TTP,将有助于更准确的诊断和应用更合适的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d450/6863018/47bcb3ef20d2/TJH-36-222-g2.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验